EHD2, a novel HIF target gene, is a promising biomarker in clear cell renal cell carcinoma

CONCLUSION: EHD2 is a novel HIF target, based on a relatively large sample of EHD2 research in patients with ccRCC. Furthermore, our study provided evidence that EHD2 can serve as a promising biomarker for predicting ccRCC outcome.PMID:38059172 | PMC:PMC10695750

Source: International Journal of Clinical and Experimental Pathology - December 7, 2023 Category: Pathology Authors: Yufeng Chen Song Xue Jian Shi Chunfeng He Qingchuan Zhang Source Type: research